Circulating HER2 DNA after trastuzumab treatment predicts survival and response in breast cancer.
about
Detection of HER2 amplification in circulating free DNA in patients with breast cancer.Breast Cancer Biomarkers: Utility in Clinical Practice.Classification of Cancer Primary Sites Using Machine Learning and Somatic Mutations.Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification.
P2860
Circulating HER2 DNA after trastuzumab treatment predicts survival and response in breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Circulating HER2 DNA after tra ...... and response in breast cancer.
@en
Circulating HER2 DNA after tra ...... and response in breast cancer.
@nl
type
label
Circulating HER2 DNA after tra ...... and response in breast cancer.
@en
Circulating HER2 DNA after tra ...... and response in breast cancer.
@nl
prefLabel
Circulating HER2 DNA after tra ...... and response in breast cancer.
@en
Circulating HER2 DNA after tra ...... and response in breast cancer.
@nl
P1433
P1476
Circulating HER2 DNA after tra ...... and response in breast cancer
@en
P2093
Jørn Andersen
Lise S Mortensen
P304
P407
P577
2010-06-01T00:00:00Z